ABSTRACT Detailed biochemical investigations of renal function were made on 75 male workers exposed to cadmium and an equal number of referents matched for age, sex, and employment status. The exposed group consisted of current and retired workers who had been employed in the manufacture ofcopper-cadmium alloy at a single factory in the United Kingdom for periods ofup to 39 years and for whom cumulative cadmium exposure indices could be calculated. In vivo measurements ofliver and kidney cadmium burden were made on exposed and referent workers using a transportable neutron activation analysis facility. Significant increases in the urinary excretion of albumin, retinol binding protein, f2 microglobulin, N-acetylglucosaminidase (NAG), alkaline phosphatase, y-glutamyl transferase and significant decreases in the renal reabsorption of calcium, urate, and phosphate were found in the exposed group compared with the referent group. Measures of glomerular filtration rate (GFR) (creatinine clearance, serum creatinine, and 2 microglobulin) indicated a reduction in GFR in the exposed population. Many of these tubular and glomerular function indicators were significantly correlated with both cumulative exposure index and liver cadmium burden. Using cumulative exposure index and liver cadmium as estimates of dose, a two phase linear regression model was applied to identify an inflection point signifying a threshold level above which changes in renal function occur. Many biochemical variables fitted this model; urinary total protein, retinol binding protein, albumin, and 2 microglobulin gave similar inflection points at cumulative exposure levels of about 1100 y.pg/m3 whereas changes in the tubular reabsorption of urate and phosphate occurred at higher cumulative exposure indices. Measures of GFR, although fitting the threshold model did not give well defined inflection points. Fewer variables fitted the two phase model using liver cadmium; those that did gave threshold levels in the range 20 3-55 1 ppm. When cadmium workers with cumulative exposure indices of less than 100 y.jig/m3 were compared with their respective referents only serum f2 microglobulin and urinary NAG were significantly increased in the exposed group and these differences were not related to the degree of cadmium exposure. Simple dose response analysis of the full exposed group showed a greatly increased incidence oftubular proteinuria when the cumulative cadmium exposure index was greater than 1.000 y.pg/m3. These cumulative exposure indices are equivalent to about 20-22 years exposure at 50 pg/im3, the current occupational exposure limit used in many countries.
The recommended occupational exposure limit for cadmium has been set to protect against the risk of renal dysfunction, usually evidenced by tubular proteinuria, after a lifetime's exposure to cadmium. Dose response data form the basis for establishing occupational exposure limits and the main response variable used to define renal dysfunction has been urinary P2 microglobulin.'°This protein undergoes degradation in acidic urine (pH < and it has been recently suggested that retinol binding protein has advantages over f2 microglobulin as an indicator of tubular proteinuria." The importance of tubular proteinuria in relation to other, possibly more clinically important, alterations in renal metabolism has not been adequately defined. There are few reports relating exposure estimates, in vivo body burden measurements, and a wide range of biochemical indicators of renal effect.
In this paper we report a study ofa group ofworkers exposed to cadmium with detailed exposure histories ofup to 39 years duration. Neutron activation analysis was used to investigate organ burden of cadmium and a comprehensive biochemical assessment of renal function was performed. Since many of the biochemical measures used to study renal function are age related, a group of unexposed reference workers who were closely matched for age as well as occupational status was included. The relation between liver cadmium as an index of body burden and a time weighted cumulative exposure index is described and models for the dose effect and dose response relations between these indices and changes in renal function are developed.
Materials and methods

STUDY POPULATION
The factory studied has produced copper-cadmium alloy, which is used for the manufacture of cables, since 1926. The alloy is produced by adding cadmium (boiling point 765°C) or master copper-cadmium alloy Mason, Davison, Wright, et al (50:50 alloy) to molten copper (melting point 1083-C) and during the process yellow brown fumes of cad. mium oxide are evolved. The production process has remained essentially the same since the factory opened, although hygiene conditions have been much improved over the years. Cadmium workers All current and ex-workers who had produced copper. cadmium alloy for one or more years since the factory opened were identified from company employment and transfer records. This resulted in a total of 185 subjects from the all male population ofwhom 76 were known to have died, three had emigrated, and three could not be traced. Of the 103 workers available for study, 101 agreed to take part in this survey. Of these, 77 were seen at the medical centre on the factory site and the remaining 24 men were seen at home and had incomplete biochemical investigations and no in vivo measurements of cadmium body burden. Only II workers were currently employed in the production of copper-cadmium alloy.
Referent workers
Male referent workers were selected from the current or past workforce of the same company, after matching for age (mean age difference = 0 4 years, SD = 2 5 years). They were all hourly paid manual workers without occupational exposure to cadmium. The factory is in an area of high unemployment and many of the workers had become unemployed, almost invariably by being made redundant. Since it has been suggested that unemployment may affect health,'2 individuals in the exposed group who were currently unemployed, or who were over 65 and had become unemployed before the normal retirement age of 65, were matched, where possible, with referents of a similar employment status. Seventy out of the 77 men seen at the medical centre were matched for employment status.
Although not individually matched for smoking histories, the proportions of current smokers, exsmokers, and non-cigarette smokers and the number of pack-years were similar in both those exposed to cadmium and referent groups.
Referents for two cadmium workers aged 79 and 83 were not obtained and thus the study population described in this paper is restricted to the 75 cadmium exposed workers (mean age 55, range A total of 933 measurements of cadmium in air had been made at the factory between 1951 and 1983. Inhalation exposure estimates for the period 1964 to 1983 were derived using 482 of these measurements (246 area or background measurements and 236 personal exposure measurements). Simultaneous area sampling and personal exposure measurements were made on 32 days. The measurements made using personal samplers were on average 20% higher than the area measurements and this figure was used to adjust all area measurements to give estimates of personal exposures.
Before 1964 sampling and analytical methods were not well standardised and before 1951 no measurements exist. Therefore, pre-1964 exposures were estimated after discussion with the occupational health physician, occupational hygienist, management, and workforce, by consideration of the available measured levels, changes in production techniques, and changes in ventilation and production levels. The estimated level for 1963 is the same as the measured level in 1964. Table 1 tabulates exposure estimates in chronological order.
Plant personnel records and occupational history showed significant differences (p < 0-01) between the cadmium exposed and referent groups; serum creatinine (p = 0-017), creatinine clearance (p = 0 034), and phosphate excretion index (p = 0-013) were margin- Table 6 shows the inflection points and 95% confidence intervals using the two phase linear regression model for those variables fitting this model. Figure 3 shows the model using urinary retinol binding protein plotted against cumulative cadmium exposure index. All variables, except creatinine clearance and kidney and urine cadmium, showed a similar pattern to fig 3 using the cadmium exposure index as independent variable-that is, a significant positive second phase gradient compared with the first gradient (creatinine clearance showed a significant negative second phase gradient compared with the first). When urinary and kidney cadmium were plotted against the exposure index, however, both showed a positive first phase gradient with the gradient after the inflection Biochemical variables for those cadmium workers with cumulative exposure indices less than 1100 y.pg/m3 were compared with their respective referents (n = 43). The cut off of 1100 y.pg/m3 was chosen since this is the common inflection point for urinary proteins using the two phase linear regression model (table 6) . Only the in vivo liver and kidney cadmium, blood and urine cadmium concentrations, urinary NAG, and serum #2microglobulin were now significantly different between groups (p < 0 05) (cftable 3). Urinary NAG and serum #2microglobulin, however, were not significantly correlated with the exposure index in this subgroup (p > 0 05). Figure 4 shows the frequency of tubular proteinuria in the full cadmium exposed group (n = 75) after dividing the workers into six exposure ranges.
Discussion
In this survey we attempted to study all workers still living who had ever been employed for more than one year in the manufacture of copper-cadmium alloy at this factory. Of the 101 workers who were traced, the 75 subjects with their respective referents who had full biochemical investigations at the medical centre form the basis of this paper. The mean age for this study population (55, range 22-75), therefore, tends to be somewhat older than in many occupational health studies. The well documented functional and Renalfunction in cadmium workers anatomical changes in the kidney with age2526 and the possible effect of employment status on health'2 are such that in an occupational health survey of a nephrotoxin such as cadmium careful selection of a well matched control group is necessary. By contrast with many studies of cadmium toxicity, this study included referent workers who had been carefully matched for age and, where possible, employment history status.
The in vivo measurements of liver and kidney cadmium and the blood and urine cadmium concentrations show that the uptake of cadmium within a proportion of the exposed group has been substantial (table 2) and is comparable with other published occupational surveys ofcadmium workers which have included in vivo neutron activation analysis measurements. 27 Many of the exposed population had ceased working with cadmium many years before our study (median = 8 years; range = 0-4 years). Therefore, cadmium body burden and cadmium concentrations in body fluids would The use of creatinine correction for urinary constituents was supported by the lack of significant differences in the rate of creatinine excretion between exposed and control groups and the absence of any relation with the cadmium exposure index. The significant differences in biochemical measures between groups (table 3) indicate a qualitative effect on renal function whereas the correlation data shown in table 4 imply that the degree of cadmium exposure exerts a quantative adverse effect. There is a lack of relation between "years off exposure" with all biochemical measures except urinary pH, when standardising for cadmium exposure index in partial correlation analysis. This may suggest that any progressive increase in dysfunction occurring after the end of exposure is not significant compared with that which can be accounted for directly by cumulative cadmium exposure.
In the present study a range of biochemical measures was used to investigate the tubular component of kidney dysfunction. Defects in tubular reabsorption of proteins were shown by a large increase in excretion of those measured proteins 799 the excretion of the higher molecular weight protein, albumin, which although largely hindered at the glomerulus also undergoes substantial reabsorption from the filtrate. Modest increases in urinary albumin concentration may thus be explained as a result of damage to the proximal tubules without the need to postulate alteration in glomerular permeability. Urinary total protein concentration was also significantly higher in the exposed group, although there is evidence that the analytical technique we used may be less sensitive to the detection of tubular rather than glomerular proteinuria.3' Calcium, urate, and phosphate each have an active transport mechanism in the proximal tubule of the nephron as a component of their renal handling and thus the observed increases in the fractional excretion of these analytes are compatible with a generalised proximal tubular dysfunction. Similar increases have been reported in a study of alkaline battery workers.32 Increases in excretion ofthe urinary enzymes of lysosomal origin (NAG) and of brush border origin (GGT and ALP) have been reported in both animal and human studies.3"35 All three enzymes are found in high concentrations in proximal tubular cells and raised urinary levels probably signify disturbance of proximal cell metabolism or cell turnover. 36 Three indicators ofglomerular filtration rate (GFR) were measured. Serum creatinine and serum fi2microglobulin are relatively insensitive to small changes in GFR3' and creatinine clearance measurements suffer a degree of imprecision even in well collected 24 hour samples. 38 The validity of a creatinine clearance calculated over three hours and the use of age correction is supported by the close agreement found between our data for the reference group (mean clearance at age 55 = 81 ml/min/1732, SD = 20) and published figures for healthy men (mean clearance, age span 50 to 59 = 81 ml/min/ 1.732, SD = 21). 39 Despite the above limitations all three measures indicated a reduction in GFR in the group exposed to cadmium compared with the referent population.
Whereas there were no significant differences in systolic and diastolic blood pressure or frequency of antihypertensive drug treatment between those exposed to cadmium and referent groups as a whole, there appeared to be a cluster of treated hypertensives among the cadmium workers with lower creatinine clearances (fig 2) . Certain antihypertensive drugs are known to reduce GFR.4 Therefore, there are at least three possible explanations for the alteration in creatinine clearance. Possibly cadmium affects the glomerulus either directly or indirectly through the tubuloglomerular feedback mechanism as a result of cadmium interference with the proximal reabsorption ofsodium and chloride.4142 Alternatively, there may be Mason, Davison, Wright, et al increased sensitivity of the cadmium compromised kidney to antihypertensive treatment. On the basis of the data available we cannot conclude whether any one or combination of these mechanisms could be responsible.
It has been suggested from animal studies that raised intracellular cadmium concentrations in the kidney may be accommodated by the induction of the cadmium binding protein, Cd-metallothionein,43 until the capacity of the renal cell to increase Cd-metallothionein synthesis is exceeded. The resulting increased free intracellular cadmium then interferes with normal cellular metabolism. This model suggests a threshold mechanism where no significant change in renal function is observed until a critical kidney cadmium concentration is reached and thereafter the dysfunction is possibly related to the concentration of nonmetallothionein bound cadmium. For this reason we examined a two phase regression model to study the relation between renal function variables and exposure estimates. It should be noted that in this model both cumulative exposure index and liver cadmium concentration are assumed to be directly related to the cadmium burden causing dysfunction in the target organ-that is, the kidney.
Data in table 6 suggest that, using the cadmium exposure index as a dose estimate, this two phase model is satisfied for many of the renal biochemical variables relating both to tubular reabsorptive processes and GFR. The mean inflection points for urinary total protein, albumin, fi2microglobulin, and retinol binding protein are similar at about 1100 y.pg/m3, suggesting that all four measures are in fact describing the effect of cadmium on the same specific renal process-that is, the tubular reabsorption of proteins."45 The fractional excretion indices of urate and phosphate have significantly higher mean inflection points than the urinary proteins. This suggests that changes in these reabsorptive processes occur either at higher target organ dose or possibly that the non-proximal tubular element of their more complex renal handling is altered, perhaps in the case of phosphate being influenced hormonally. Two measures ofGFR, serum f2microglobulin and creatinine clearance, satisfied the necessary criteria for the two phase regression model using cumulative exposure index but there was a large uncertainty in the inflection points. The inflection point obtained for urinary NAG against cadmium exposure index may reflect the early disturbances in the lysosomal system that have been reported in studies of animal models of the cellular effects of cadmium nephrotoxicity.' The two phase model for kidney cadmium against cadmium exposure index, which shows a secondary nonsignificant gradient after the positive initial phase, possibly reflects the accelerated rate of cadmium loss from this organ after the development of renal dysfunction.
Fewer biochemical variables fitted the two phase model using liver cadmium as indicator of body burden. Those that did (total protein, albumin, fi2microglobulin, retinol binding protein, NAG, fractional excretion of urate, serum creatinine, and creatinine clearance) gave mean inflection points in the range 20-3-55 1 ppm liver cadmium. This range of liver cadmium inflection points encompasses values found in two surveys reported by Chettle et al using total protein and #2microglobulin as response variables,47 and is similar to the value of 40 ppm quoted by Ellis et al who used fi2microglobulin as an indicator of change in renal status.0
The wide confidence intervals associated with the various inflection points when using either cadmium exposure index or liver cadmium may be a consequence of several factors; the interindividual and intraindividual variation in the biochemical parameters measured, the inherent errors in estimating a historical exposure index, the effect of biological half life ofcadmium in the liver, and also that, within a population, there will be a range of thresholds corresponding to an individual's ability to induce increased amounts of intracellular metallothionein.
Using the cumulative exposure index, changes in the tubular reabsorption of proteins appear at similar inflection points of about 1100 y.pg/m3 with lower there is a qualitative change in renal function. Below this exposure range the frequency of retinol binding proteinuria is no greater than that found in the referent population; within and above this exposure range the prevalence of this proteinuria is greater than 55%.
When those cadmium workers with cumulative exposure indices above 1100 y.pg/m3 and their respective controls were excluded from the population only two biochemical variables, serum f2micro-globulin and urinary NAG, showed significant differences between exposed and referent groups. The degree of both differences was unrelated to the cadmium exposure index. Urinary NAG may be marginally increased in many renal pathological conditions and in the renal handling of several drugs at therapeutic levels. The statistically significant but small increase in serum fi2microglobulin seen in this 801 subgroup analysis may suggest some reduction in GFR, although apparently not directly related to the amount ofcadmium exposure. The lack of substantiation by the other measures of GFR, however, could be interpreted as indicating a small alteration in the production rate of #2microglobulin rather than its renal handling.
In summary, this study confirms other surveys of cadmium workers which have found evidence of generalised dysfunction of reabsorptive processes located in the proximal tubules and damage to these cells. We have shown that these effects are related to the degree of cadmium exposure as measured by cumulative exposure index and liver cadmium concentration. The progressive element of all dysfunctions (except the excretion of hydrogen ions) in the absence of continuing exposure, does not appear to be significant compared with that which can be accounted for by cumulative cadmium exposure. Many of the biochemical variables related to tubular and glomerular filtration fit the dose effect model developed from the known intracellular metabolism of cadmium. The statistically, and possibly clinically, significant changes in GFR also appear to be related by some mechanism to exposure to cadmium, although the physiological balance mechanisms between tubular and glomerular functions do not allow definition ofthe specific site ofthe cadmium effect. The effect of antihypertensive treatment on GFR may confound, to an extent, the observed reduction between exposed and control groups.
Several investigators have attempted to develop quantitative estimates of cumulative cadmium exposure and to relate these to changes in renal function. Ellis et al reported evidence of renal abnormalities when the exposure index exceeded 400-500 y.yg/m3.0 Smith et al reported significant renal effects with average cumulative inhalation exposures of 1575 y.yg/m3.' Falck et al suggested that those cadmium workers with renal dysfunction had a mean exposure of 1137 y.pg/m3 6 and Elinder et al found only a few cases of slight fi2microglobulinuria in workers with cumulative exposures of less than 1000 y.yg/m3.' Dose effect, dose response, and subgroup analysis of our data suggest that a maximum level of 1100 y.pg/m3 may prevent the development of changes in renal function. This cumulative exposure index is equivalent to about 22 years exposure at 50 pg/M3, the current occupational exposure limit used in many countries.
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